As of 2026-03-28, the Relative Valuation of Abbvie Inc (ABBV) is 78.47 USD. This relative valuation is based on P/E multiples. With the latest stock price at 209.40 USD, the upside of Abbvie Inc based on Relative Valuation is -62.5%.
The range of the Relative Valuation is 58.56 - 96.07 USD.
| Range | Selected | |
| Trailing P/E multiples | 24.5x - 28.6x | 27.4x |
| Forward P/E multiples | 23.1x - 25.6x | 24.4x |
| Fair Price | 58.56 - 96.07 | 78.47 |
| Upside | -72.0% - -54.1% | -62.5% |
| Date | P/E |
| 2026-03-27 | 87.61 |
| 2026-03-26 | 88.33 |
| 2026-03-25 | 86.68 |
| 2026-03-24 | 85.86 |
| 2026-03-23 | 85.74 |
| 2026-03-20 | 85.80 |
| 2026-03-19 | 86.29 |
| 2026-03-18 | 87.17 |
| 2026-03-17 | 91.95 |
| 2026-03-16 | 92.66 |
| 2026-03-13 | 91.91 |
| 2026-03-12 | 94.30 |
| 2026-03-11 | 95.26 |
| 2026-03-10 | 94.98 |
| 2026-03-09 | 95.17 |
| 2026-03-06 | 96.28 |
| 2026-03-05 | 97.22 |
| 2026-03-04 | 98.82 |
| 2026-03-03 | 97.85 |
| 2026-03-02 | 98.02 |
| 2026-02-27 | 97.10 |
| 2026-02-26 | 94.01 |
| 2026-02-25 | 94.94 |
| 2026-02-24 | 95.58 |
| 2026-02-23 | 96.02 |
| 2026-02-20 | 94.06 |
| 2026-02-19 | 93.87 |
| 2026-02-18 | 95.70 |
| 2026-02-17 | 97.43 |
| 2026-02-13 | 96.86 |
| 2026-02-12 | 95.19 |
| 2026-02-11 | 92.42 |
| 2026-02-10 | 93.07 |
| 2026-02-09 | 93.41 |
| 2026-02-06 | 93.48 |
| 2026-02-05 | 91.64 |
| 2026-02-04 | 90.84 |
| 2026-02-03 | 94.42 |
| 2026-02-02 | 94.41 |
| 2026-01-30 | 93.31 |
| 2026-01-29 | 92.23 |
| 2026-01-28 | 91.49 |
| 2026-01-27 | 93.69 |
| 2026-01-26 | 92.37 |
| 2026-01-23 | 91.74 |
| 2026-01-22 | 91.26 |
| 2026-01-21 | 90.44 |
| 2026-01-20 | 89.55 |
| 2026-01-16 | 89.68 |
| 2026-01-15 | 90.69 |